Intrauterine Insemination and Intra-Fertility

Intrauterine insemination (IUI) is a simpler form of assisted conception in which prepared, motile sperm are placed directly into the uterine cavity around the time of ovulation, bypassing the cervix to bring more sperm closer to the oocyte. It is often combined with mild ovarian stimulation and is commonly used for unexplained or mild male-factor subfertility and for donor sperm, occupying a step between natural conception and IVF.

Definition

Intrauterine insemination is the placement of washed, prepared sperm into the uterine cavity through a thin catheter, timed to ovulation, with or without ovarian stimulation. Because it does not involve retrieving or handling oocytes outside the body, it is generally classified separately from oocyte-based assisted reproductive technology.

Scope

The topic covers the rationale and method of IUI, the preparation of sperm, the role of ovulation timing and optional ovarian stimulation, the indications for which it is used, and the evidence on its effectiveness relative to expectant management or timed intercourse and to IVF. By convention IUI involves no oocyte retrieval, so many registries treat it as distinct from IVF-based ART; it is presented here as a reference entry, not a treatment protocol.

Core questions

• How does intrauterine insemination differ mechanistically from natural conception and from IVF?
• Why is sperm washed and prepared before insemination, and how is timing chosen?
• For which indications is IUI used, and when is it combined with ovarian stimulation?
• How effective is IUI compared with expectant management or with proceeding to IVF?

Key concepts

• Sperm washing and preparation
• Ovulation timing
• Stimulated versus natural-cycle IUI
• Unexplained subfertility
• Mild male-factor subfertility
• Donor insemination
• Multiple pregnancy with stimulation
• Step-wise approach to IVF

Mechanisms

In IUI, a semen sample is washed to remove seminal plasma and to concentrate motile sperm, which are then introduced directly into the uterine cavity through a soft catheter, bypassing the cervix and depositing a larger number of motile sperm closer to the fallopian tubes around the time of ovulation. Timing may follow a natural cycle or an ovulation trigger, and mild ovarian stimulation is often added to increase the number of available oocytes, which raises pregnancy rates but also the risk of multiple pregnancy. Systematic review supports IUI, particularly with ovarian stimulation, over expectant management for unexplained subfertility (Veltman-Verhulst et al., 2016). Unlike IVF, no oocytes are retrieved, so fertilization occurs within the body.

Clinical relevance

IUI is a widely used first-line option for several causes of subfertility and for the use of donor sperm, and understanding where it sits relative to IVF informs how treatment pathways are structured. This entry describes the procedure and its evidence for reference and appraisal; it does not give individualized treatment recommendations, drug regimens, or eligibility criteria.

Epidemiology

IUI is most commonly applied to unexplained subfertility, mild male-factor subfertility, and situations requiring donor sperm. Its effectiveness is modest but meaningful relative to no treatment, especially when combined with ovarian stimulation (Veltman-Verhulst et al., 2016). Because stimulation increases multiple-follicle development, stimulated IUI carries a recognized risk of multiple pregnancy, which influences how it is used. Cumulative success is generally lower per cycle than IVF, and patients who do not conceive may step up to IVF-based treatment (Moragianni & Penzias, 2010).

Evidence & guidelines

The central evidence is the Cochrane systematic review of IUI for unexplained subfertility (Veltman-Verhulst et al., 2016), complemented by trials and meta-analyses of stimulation strategies relevant to assisted conception (Kadoura et al., 2022); professional bodies such as ESHRE, ASRM, and national guideline groups address the place of IUI in treatment pathways. Specific indications and regimens are not reproduced here.

History

Artificial insemination has a long history in both animal breeding and human medicine, predating IVF by many decades. The development of reliable sperm-washing and preparation methods made intrauterine, rather than intracervical, insemination practical, and the later pairing of IUI with ovarian stimulation increased its effectiveness. As IVF became established, IUI settled into its present role as a less invasive, lower-cost option used before or instead of IVF for selected indications, with its relative effectiveness clarified by systematic review (Veltman-Verhulst et al., 2016).

Debates

IUI versus immediate IVF or expectant management

For unexplained subfertility, the optimal first step is debated: IUI with ovarian stimulation outperforms expectant management in systematic review, but whether to offer IUI before IVF, or proceed directly to IVF, depends on prognosis, cost, and the risk of multiple pregnancy.

Stimulated versus natural-cycle IUI

Adding ovarian stimulation to IUI raises pregnancy rates but increases multiple-follicle development and the risk of multiple pregnancy, so the trade-off between effectiveness and safety in the choice of stimulation remains contested.

Seminal works

• veltman-verhulst-2016

Frequently asked questions

Is intrauterine insemination the same as IVF?

No. In IUI, prepared sperm are placed into the uterus and fertilization occurs naturally inside the body, with no egg retrieval. IVF retrieves oocytes and fertilizes them in the laboratory. IUI is simpler and less invasive, and many registries classify it separately from IVF-based assisted reproductive technology.

Why is intrauterine insemination often combined with ovarian stimulation?

Mild stimulation can increase the number of oocytes available in a cycle, which raises the chance of pregnancy compared with insemination in a natural cycle. The trade-off is a higher risk of multiple pregnancy, which is why stimulation in this setting is used carefully.